Review
Published on 27 Oct 2022
Hemophagocytic lymphohistiocytosis as an etiology of bone marrow failure
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1016318
- 13,930 views
- 14 citations
Type at least 3 characters
2,058 articles
articles
Review
Published on 27 Oct 2022
Advances in the molecular characterization of multiple myeloma and mechanism of therapeutic resistance
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1020011
- 6,556 views
- 11 citations
Review
Published on 27 Oct 2022
The path towards consensus genome classification of diffuse large B-cell lymphoma for use in clinical practice
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.970063
- 4,863 views
- 5 citations
Review
Published on 26 Oct 2022
High-cutoff hemodialysis in multiple myeloma patients with acute kidney injury
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1024133
- 10,934 views
- 9 citations
Review
Published on 25 Oct 2022
PAX5 alterations in B-cell acute lymphoblastic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1023606
- 19,901 views
- 39 citations
Case Report
Published on 24 Oct 2022
CD19 chimeric antigen receptor T-cell therapy following autologous stem cell transplantation against relapsed or refractory Burkitt lymphoma/leukemia: A case report and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.932254
- 3,113 views
- 4 citations
Case Report
Published on 24 Oct 2022
Angioimmunoblastic T-cell lymphoma with extensive follicular dendritic cell and fibroblastic reticular cell network proliferation mimicking follicular dendritic cell sarcoma: A case report with pathologic, immunophenotypic, and molecular findings
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.983585
- 3,507 views
Review
Published on 20 Oct 2022
The genetics of myelodysplastic syndromes and the opportunities for tailored treatments
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.989483
- 12,543 views
- 14 citations
Case Report
Published on 19 Oct 2022
Inherited heterozygous Fanconi anemia gene mutations in a therapy-related CMML patient with a rare NUP98-HOXC11 fusion: A case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1036511
- 4,909 views
- 3 citations
Original Research
Published on 18 Oct 2022
A bone-based 3D scaffold as an in-vitro model of microenvironment–DLBCL lymphoma cell interaction
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.947823
- 6,404 views
- 15 citations
Opinion
Published on 18 Oct 2022
Beyond 8-methoxypsoralen as the photosensitizer for extracorporeal photopheresis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.996973
- 2,900 views
- 1 citation
Case Report
Published on 18 Oct 2022
Case report: Simultaneous occurrence of primary pulmonary lymphoma and opportunistic infections in a patient with chronic myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1031500
- 2,568 views
- 3 citations
Review
Published on 18 Oct 2022
Bispecific antibodies in multiple myeloma treatment: A journey in progress
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1032775
- 30,744 views
- 48 citations
Review
Published on 18 Oct 2022
Deregulated calcium signaling in blood cancer: Underlying mechanisms and therapeutic potential
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1010506
- 8,464 views
- 9 citations
Mini Review
Published on 13 Oct 2022
NOTCH1 Signalling: A key pathway for the development of high-risk chronic lymphocytic leukaemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1019730
- 7,308 views
- 6 citations
Original Research
Published on 13 Oct 2022
Clinical characteristics and prognostic value of renal immune complex deposition in patients with light chain amyloidosis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.949702
- 2,236 views
- 2 citations
Review
Published on 12 Oct 2022
Targeting CD38 for acute leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1007783
- 10,382 views
- 19 citations
Original Research
Published on 12 Oct 2022
Development and validation of a novel prognosis prediction model for patients with myelodysplastic syndrome
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1014504
- 4,057 views
Original Research
Published on 12 Oct 2022
Efficacy and safety of decitabine combined with HAAG (homoharringtonine, aclarubicin, low-dose cytarabine and G-CSF) for newly diagnosed acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.998884
- 3,619 views
- 4 citations
Editorial
Published on 10 Oct 2022
Editorial: COVID-19 and hematological malignancies: Volume II
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1044582
- 1,806 views
Original Research
Published on 10 Oct 2022
Concordance in measurable residual disease result after first and second induction cycle in acute myeloid leukemia: An outcome- and cost-analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.999822
- 5,032 views
- 6 citations
Original Research
Published on 07 Oct 2022
Significance of bone marrow fibrosis in acute myeloid leukemia for survival in the real-world
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.971082
- 6,086 views
- 6 citations
Original Research
Published on 07 Oct 2022
A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.966920
- 7,569 views
- 28 citations
Original Research
Published on 07 Oct 2022
The independent adverse prognostic significance of 1q21 gain/amplification in newly diagnosed multiple myeloma patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.938392
- 6,326 views
- 15 citations